Multiple cancer-associated genes are significantly downregulated in the translatome upon shMSI1 inhibition, including MAP3K13, transcriptional enhancers of MYC and genes essential in early development, NPM1 and KMT2A, respectively. The gene discussed is KMT2A; the disease is cancer.